Geburtshilfe und Frauenheilkunde

LinksSchließen

Referenz

Huober J, Weder P, Veyret C. et al.
PERNETTA – A non comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2 positive metastatic breast cancer (SAKK 22/10/UNICANCER UC-0140/1207).

Ann Oncol 2018;
29: mdy272.280

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: